Last 0.86 NOK
Change Today -0.02 / -2.27%
Volume 405.3K
DIAG On Other Exchanges
Symbol
Exchange
Berlin
As of 8:29 AM 08/28/14 All times are local (Market data is delayed by at least 15 minutes).

diagenic asa (DIAG) Snapshot

Open
0.88 NOK
Previous Close
0.88 NOK
Day High
0.88 NOK
Day Low
0.86 NOK
52 Week High
02/26/14 - 2.00 NOK
52 Week Low
12/16/13 - 0.47 NOK
Market Cap
93.0M
Average Volume 10 Days
226.8K
EPS TTM
-1.07 NOK
Shares Outstanding
108.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for DIAGENIC ASA (DIAG)

Related News

No related news articles were found.

diagenic asa (DIAG) Related Businessweek News

No Related Businessweek News Found

diagenic asa (DIAG) Details

DiaGenic ASA researches, develops, sells, and markets blood based gene expression tests. The company was founded in 1998 and is headquartered in Oslo, Norway.

11 Employees
Last Reported Date: 03/21/14
Founded in 1998

diagenic asa (DIAG) Top Compensated Officers

Chief Financial Officer
Total Annual Compensation: 1.2M NOK
Compensation as of Fiscal Year 2013.

diagenic asa (DIAG) Key Developments

DiaGenic ASA, Q2 2014 Earnings Call, Aug 21, 2014

DiaGenic ASA, Q2 2014 Earnings Call, Aug 21, 2014

DiaGenic ASA Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

DiaGenic ASA reported unaudited earnings results for the second quarter and six months ended June 30, 2014. For the quarter, operating loss was NOK 908,000 against NOK 11,121,000 a year ago. Pre-tax loss was NOK 635,000 against NOK 10,951,000 a year ago. Net loss was NOK 635,000 or NOK 0.00 per share after dilution against NOK 10,951,000 or NOK 1 per share after dilution a year ago. Net cash outflow from operating activities was NOK 1,747,000 against NOK 11,509,000 a year ago. For the six months, operating loss was NOK 5,345,000 against NOK 20,876,000 a year ago. Pre-tax loss was NOK 5,016,000 against NOK 20,652,000 a year ago. Net loss was NOK 5,016,000 or NOK 0.00 per share after dilution against NOK 20,652,000 or NOK 4 per share after dilution a year ago. Net cash outflow from operating activities was NOK 7,945,000 against NOK 20,441,000 a year ago.

DiaGenic ASA Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2014

DiaGenic ASA announced unaudited earnings results for the first quarter ended March 31, 2014. For the quarter, operating loss was NOK 4,437,000 against NOK 9,755,000 a year ago. Pre-tax loss was NOK 4,381,000 against NOK 9,701,000 a year ago. Net loss was NOK 4,381,000 or NOK 0.54 per share after dilution against NOK 9,701,000 or NOK 3.39 per share after dilution a year ago. Net cash outflow from operating activities was NOK 6,433,000 against NOK 8,515,000 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DIAG:NO 0.86 NOK -0.02

DIAG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
DiaxonHit €0.68 EUR +0.04
View Industry Companies
 

Industry Analysis

DIAG

Industry Average

Valuation DIAG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 79.1x
Price/Book 1.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 989.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DIAGENIC ASA, please visit www.diagenic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.